Conditions: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Interventions: Biological: Ipilimumab; Biological: Nivolumab; Biological: VX15/2503; Procedure: Surgery
Sponsors: Emory University; Bristol-Myers Squibb; Vaccinex Inc.; National Institutes of Health (NIH); National Cancer Institute (NCI)
Active, not recruiting